1. Home
  2. SBET vs ABCL Comparison

SBET vs ABCL Comparison

Compare SBET & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SharpLink Gaming Ltd.

SBET

SharpLink Gaming Ltd.

HOLD

Current Price

$6.28

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$5.18

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBET
ABCL
Founded
1995
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
SBET
ABCL
Price
$6.28
$5.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
5
Target Price
$18.71
$8.40
AVG Volume (30 Days)
6.3M
8.8M
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.91
EPS
N/A
N/A
Revenue
$28,055,000.00
$75,128,000.00
Revenue This Year
$105.19
N/A
Revenue Next Year
$13.53
$21.85
P/E Ratio
N/A
N/A
Revenue Growth
666.04
160.56
52 Week Low
$5.96
$1.97
52 Week High
$124.12
$6.52

Technical Indicators

Market Signals
Indicator
SBET
ABCL
Relative Strength Index (RSI) 39.02 64.05
Support Level $6.05 $3.32
Resistance Level $8.20 $5.63
Average True Range (ATR) 0.37 0.45
MACD -0.13 0.00
Stochastic Oscillator 9.37 73.67

Price Performance

Historical Comparison
SBET
ABCL

About SBET SharpLink Gaming Ltd.

SharpLink Inc is one of those publicly traded companies to adopt ETH as its primary treasury reserve asset. This move reflects the Company's commitment to align corporate treasury with the future of programmable finance, digital capital markets, and decentralized infrastructure. The Company also operates an online affiliate marketing company that delivers different fan activation solutions to its sportsbook and online casino gaming partners. The company operates in two reportable segments: ETH Treasury Management and Affiliate Marketing. The majority of its revenue is generated from the ETH Treasury Management. Geographically, the company operates in the United States and the rest of the world.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: